Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Boozt | BOOZTDKK | 22. nov 2024 | 68.80 | +1.70 |
Brain+ | BRAINP | 22. nov 2024 | 0.10 | +5.32 |
Brd. Klee B | KLEEB | 22. nov 2024 | 3 840.00 | +0.52 |
Brdr. A & O Johansen Pref B | AOJB | 22. nov 2024 | 81.20 | +4.91 |
Brøndbyernes IF Fodbold | BIF | 22. nov 2024 | 0.52 | 0.00 |
Carlsberg A | CARLA | 22. nov 2024 | 836.00 | -0.24 |
Carlsberg B | CARLB | 22. nov 2024 | 737.80 | +2.08 |
cBrain | CBRAIN | 22. nov 2024 | 203.00 | +3.15 |
Cemat | CEMAT | 22. nov 2024 | 1.05 | -0.94 |
Cessatech A/S | CESSA | 22. nov 2024 | 14.40 | -1.37 |
ChemoMetec | CHEMM | 22. nov 2024 | 472.40 | +4.47 |
Coloplast B | COLOB | 22. nov 2024 | 891.60 | +2.11 |
Columbus | COLUM | 22. nov 2024 | 10.60 | +0.47 |
Conferize | CONFRZ | 22. nov 2024 | 0.01 | 0.00 |
Copenhagen Capital | CPHCAPST | 22. nov 2024 | 5.05 | 0.00 |
Copenhagen Capital 40 pct Pref 2032 | CPHCAPPREF32 | 22. nov 2024 | 8.10 | 0.00 |
CS Medica | CSMED | 22. nov 2024 | 3.81 | +1.06 |
D/S Norden | DNORD | 22. nov 2024 | 220.40 | +1.47 |
Danish Aerospace Company | DAC | 22. nov 2024 | 3.16 | -9.20 |
Danske Andelskassers Bank | DAB | 22. nov 2024 | 12.75 | -0.39 |
Danske Bank | DANSKE | 22. nov 2024 | 201.90 | -0.79 |
Dantax | DANT | 22. nov 2024 | 396.00 | +0.51 |
Dataproces Group | DATA | 22. nov 2024 | 5.85 | -1.68 |
DecideAct | ACT | 22. nov 2024 | 1.80 | 0.00 |
Demant | DEMANT | 22. nov 2024 | 266.20 | +3.18 |
Det Ostasiatiske Kompagni A/S | OKEAC | 22. nov 2024 | 9 350.00 | 0.00 |
DFDS | DFDS | 22. nov 2024 | 141.30 | +0.57 |
Djurslands Bank | DJUR | 22. nov 2024 | 515.00 | -1.90 |
Donkey Republic | DONKEY | 22. nov 2024 | 6.40 | +4.07 |
DSV | DSV | 22. nov 2024 | 1 504.00 | -0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.